SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $47.96 million. The enterprise value is -$9.24 million.
| Market Cap | 47.96M |
| Enterprise Value | -9.24M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 9.93 million shares outstanding. The number of shares has increased by 3.08% in one year.
| Current Share Class | 9.93M |
| Shares Outstanding | 9.93M |
| Shares Change (YoY) | +3.08% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 19.12% |
| Float | 7.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.36 |
| Forward PS | 31.43 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 1.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.94 |
| Quick Ratio | 3.73 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.39% and return on invested capital (ROIC) is -136.41%.
| Return on Equity (ROE) | -53.39% |
| Return on Assets (ROA) | -20.96% |
| Return on Invested Capital (ROIC) | -136.41% |
| Return on Capital Employed (ROCE) | -39.53% |
| Weighted Average Cost of Capital (WACC) | 9.90% |
| Revenue Per Employee | $1.13M |
| Profits Per Employee | -$1.36M |
| Employee Count | 18 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.28% in the last 52 weeks. The beta is 1.10, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -26.28% |
| 50-Day Moving Average | 5.09 |
| 200-Day Moving Average | 5.90 |
| Relative Strength Index (RSI) | 55.08 |
| Average Volume (20 Days) | 96,568 |
Short Selling Information
The latest short interest is 380,838, so 3.84% of the outstanding shares have been sold short.
| Short Interest | 380,838 |
| Short Previous Month | 320,181 |
| Short % of Shares Out | 3.84% |
| Short % of Float | 4.95% |
| Short Ratio (days to cover) | 4.90 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $20.34 million and -$24.52 million in losses. Loss per share was -$3.90.
| Revenue | 20.34M |
| Gross Profit | 20.34M |
| Operating Income | -24.40M |
| Pretax Income | -24.52M |
| Net Income | -24.52M |
| EBITDA | n/a |
| EBIT | -24.40M |
| Loss Per Share | -$3.90 |
Balance Sheet
The company has $59.26 million in cash and $2.06 million in debt, with a net cash position of $57.20 million or $5.76 per share.
| Cash & Cash Equivalents | 59.26M |
| Total Debt | 2.06M |
| Net Cash | 57.20M |
| Net Cash Per Share | $5.76 |
| Equity (Book Value) | 41.31M |
| Book Value Per Share | 5.33 |
| Working Capital | 46.79M |
Cash Flow
| Operating Cash Flow | -5.92M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -5.92M |
| FCF Per Share | -$0.60 |
Margins
Gross margin is 100.00%, with operating and profit margins of -119.95% and -120.51%.
| Gross Margin | 100.00% |
| Operating Margin | -119.95% |
| Pretax Margin | -120.51% |
| Profit Margin | -120.51% |
| EBITDA Margin | n/a |
| EBIT Margin | -119.95% |
| FCF Margin | n/a |
Dividends & Yields
SCYNEXIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.08% |
| Shareholder Yield | -3.08% |
| Earnings Yield | -51.12% |
| FCF Yield | -12.34% |
Analyst Forecast
The average price target for SCYNEXIS is $33.55, which is 594.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.55 |
| Price Target Difference | 594.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -11.91% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2026. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
SCYNEXIS has an Altman Z-Score of -6.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.84 |
| Piotroski F-Score | 2 |